Skip to main content
. 2019 Nov 12;75(2):394–400. doi: 10.1093/gerona/gly279

Table 1.

Demography and Medical History of Participants

Mean (SD)/Frequency (%)
Number of participants (N) 1,814
% Men 939 (51.8%)
Race % White 1,353 (74.6%)
% African American 358 (19.7%)
% Other 103 (5.7%)
Age at baseline (y) 59.7 (16.4)
Range 17.7–94.5
Education (y) 16.2 (2.6)
Range 8–21
Total number of urine samples 5,527
Number of repeat measures 3.0 (2.2)
Range 1–12
Follow-up duration 6.6 (6.9)
Range 0–31.2 years
Duration of storage (y) 11.9 (6.4)
Range 2.0–48.1
Medication Frequency (%) by visita Frequency (%) by participantb
 Diruetics 902 (16.3%) 443 (24.4%)
 Antidepressant 407 (7.4%) 237 (13.1%)
 Sedatives 269 (4.9%) 196 (10.8%)
 Thyroid hormone 963 (17.4%) 476 (26.2%)
 Diabetes 334 (6.0%) 148 (8.2%)
 Statins 1,244 (22.5%) 566 (31.2%)
 Corticosteroids 523 (9.5%) 363 (20.0%)
 Sex hormones 876 (15.9%) 411 (22.7%)
 Smoking status 268 (4.9%) current
2,832 (51.2%) former
2,427 (43.9%) never
Medical condition
 Congestive heart failure 59 (1.1%) 26 (1.4%)
 Myocardial infarction 283 (5.1%) 111 (6.1%)
 Hypertension 2,027 (36.7%) 694 (38.3%)
 Angina 589 (10.7%) 200 (11.0%)
 Diabetes 369 (6.7%) 137 (7.6%)
 Cancer 748 (13.5%) 281 (15.5%)

aFrequency (%) of medication usage across all 5,527 visits.

bFrequency (%) of medication usage by participant (N = 1,814) at any visit.